The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma
Open Access
- 6 August 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Hematology & Oncology
- Vol. 13 (1), 1-15
- https://doi.org/10.1186/s13045-020-00933-y
Abstract
Background Multiple Myeloma (MM) is a hematological malignancy with genomic heterogeneity and poor survival outcome. Apart from the central role of genetic lesions, epigenetic anomalies have been identified as drivers in the development of the disease. Methods Alterations in the DNA methylome were mapped in 52 newly diagnosed MM (NDMM) patients of six molecular subgroups and matched with loci-specific chromatin marks to define their impact on gene expression. Differential DNA methylation analysis was performed using DMAP with a >= 10% increase (hypermethylation) or decrease (hypomethylation) in NDMM subgroups, compared to control samples, considered significant for all the subsequent analyses with pResults We identified differentially methylated regions (DMRs) within the etiological cytogenetic subgroups of myeloma, compared to control plasma cells. Using gene expression data we identified genes that are dysregulated and correlate with DNA methylation levels, indicating a role for DNA methylation in their transcriptional control. We demonstrated that 70% of DMRs in the MM epigenome were hypomethylated and overlapped with repressive H3K27me3. In contrast, differentially expressed genes containing hypermethylated DMRs within the gene body or hypomethylated DMRs at the promoters overlapped with H3K4me1, H3K4me3, or H3K36me3 marks. Additionally, enrichment of BRD4 or MED1 at the H3K27ac enriched DMRs functioned as super-enhancers (SE), controlling the overexpression of genes or gene-cassettes. Conclusions Therefore, this study presents the underlying epigenetic regulatory networks of gene expression dysregulation in NDMM patients and identifies potential targets for future therapies.Funding Information
- Leukemia and Lymphoma Society (6602-20)
This publication has 44 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Pre-mRNA splicing is a determinant of histone H3K36 methylationProceedings of the National Academy of Sciences of the United States of America, 2011
- H3K4 tri-methylation provides an epigenetic signature of active enhancersThe EMBO Journal, 2011
- Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myelomaBlood, 2011
- Regulation of Alternative Splicing by Histone ModificationsScience, 2010
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight reviewLeukemia, 2009
- Differential repetitive DNA methylation in multiple myeloma molecular subgroupsCarcinogenesis: Integrative Cancer Research, 2009
- A clustering approach for identification of enriched domains from histone modification ChIP-Seq dataBioinformatics, 2009
- Genome Regulation by Polycomb and Trithorax ProteinsCell, 2007
- The molecular classification of multiple myelomaBlood, 2006